Knockdown of Elf5 in basal breast cancer cells also resulted in a shift in their molecular signature toward a claudin-low and normal-like subtype of breast cancer suggesting that Elf5 is a key determinant of breast cancer intrinsic molecular subtype. This evidence concerns the gene ELF5 and breast cancer.